Cardiac Progenitor Cell Cycling Stimulated by Pim-1 Kinase
暂无分享,去创建一个
Mark A Sussman | N. Gude | D. Avitabile | Pearl J Quijada | John A. Muraski | Brandi Bailey | Christopher T Cottage | Kimberlee M. Fischer | B. Collins | Roberto Alvarez | S. Tuck | Christopher T. Cottage
[1] Mark A Sussman,et al. Cardiac stem cell genetic engineering using the alphaMHC promoter. , 2009, Regenerative medicine.
[2] R. Bolli,et al. Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells , 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[3] R. D. de Boer,et al. Early Beneficial Effects of Bone Marrow‐Derived Mesenchymal Stem Cells Overexpressing Akt on Cardiac Metabolism After Myocardial Infarction , 2009, Stem cells.
[4] M. Goumans,et al. Cell therapy for myocardial regeneration. , 2009, Current molecular medicine.
[5] T. McDonnell,et al. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death , 2009, Apoptosis.
[6] M. Hesse,et al. c-kit expression identifies cardiovascular precursors in the neonatal heart , 2009, Proceedings of the National Academy of Sciences.
[7] G. Vereb,et al. Die hard: Are cancer stem cells the Bruce Willises of tumor biology? , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[8] M. Gnecchi,et al. Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.
[9] Joseph C. Wu. Molecular imaging: antidote to cardiac stem cell controversy. , 2008, Journal of the American College of Cardiology.
[10] Seppo Ylä-Herttuala,et al. Overexpression of Vascular Endothelial Growth Factor-B in Mouse Heart Alters Cardiac Lipid Metabolism and Induces Myocardial Hypertrophy , 2008, Circulation research.
[11] C. Bearzi,et al. Cardiac stem cells and myocardial disease. , 2008, Journal of molecular and cellular cardiology.
[12] S. Houser,et al. Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload , 2008, Proceedings of the National Academy of Sciences.
[13] Z. Wang,et al. Pim kinase-dependent inhibition of c-Myc degradation , 2008, Oncogene.
[14] Mark A Sussman,et al. Activation of Notch-Mediated Protective Signaling in the Myocardium , 2008, Circulation research.
[15] Mark A Sussman,et al. Evolution of the c‐kit‐Positive Cell Response to Pathological Challenge in the Myocardium , 2008, Stem cells.
[16] W. Zhong,et al. Neurogenesis and asymmetric cell division , 2008, Current Opinion in Neurobiology.
[17] J. Chang,et al. Current Status and Issues in Cancer Stem Cell Study , 2008, Cancer investigation.
[18] Jacques Corbeil,et al. Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents , 2008, Clinical Cancer Research.
[19] Kim-Anh Do,et al. Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer , 2008, BMC Medical Genomics.
[20] Marielle Afanassieff,et al. Self‐Renewal of Murine Embryonic Stem Cells Is Supported by the Serine/Threonine Kinases Pim‐1 and Pim‐3 , 2007, Stem cells.
[21] Mark A Sussman. "AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. , 2007, Trends in cardiovascular medicine.
[22] N. Magnuson,et al. Pim-1 Kinase-Dependent Phosphorylation of p21Cip1/WAF1 Regulates Its Stability and Cellular Localization in H1299 Cells , 2007, Molecular Cancer Research.
[23] M. Steenman,et al. The prokineticin receptor‐1 (GPR73) promotes cardiomyocyte survival and angiogenesis , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] Kui Liu,et al. MEK1/2 Regulates Microtubule Organization, Spindle Pole Tethering and Asymmetric Division During Mouse Oocyte Meiotic Maturation , 2007, Cell cycle.
[25] S. Houser,et al. Pim-1 regulates cardiomyocyte survival downstream of Akt , 2006, Nature Medicine.
[26] Anthony J. Muslin,et al. Akt2 Regulates Cardiac Metabolism and Cardiomyocyte Survival* , 2006, Journal of Biological Chemistry.
[27] I. Shiojima,et al. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. , 2006, Physiological genomics.
[28] Mark A Sussman,et al. Akt Promotes Increased Cardiomyocyte Cycling and Expansion of the Cardiac Progenitor Cell Population , 2006, Circulation research.
[29] Mark A Sussman,et al. Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy , 2006, Proceedings of the National Academy of Sciences.
[30] C. Bearzi,et al. Stem cell niches in the adult mouse heart. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[31] Anthony J. Muslin,et al. Akt1 Is Required for Physiological Cardiac Growth , 2006, Circulation.
[32] A. Rosenzweig,et al. Effects of chronic Akt activation on glucose uptake in the heart. , 2006, American journal of physiology. Endocrinology and metabolism.
[33] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] P. Petersen,et al. The Enigma of the Numb-Notch Relationship during Mammalian Embryogenesis , 2006, Developmental Neuroscience.
[35] H. Schatten,et al. Role of NuMA in vertebrate cells: review of an intriguing multifunctional protein. , 2006, Frontiers in bioscience : a journal and virtual library.
[36] M. Beckerle,et al. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. , 2005, The Journal of clinical investigation.
[37] P. Anversa,et al. Cardiac stem cells and mechanisms of myocardial regeneration. , 2005, Physiological reviews.
[38] D. Torella,et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] P. Hammerman,et al. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. , 2005, Blood.
[40] A. Levine,et al. The p53 pathway: positive and negative feedback loops , 2005, Oncogene.
[41] P. Meltzer,et al. Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival. , 2005, Blood.
[42] M. Soonpaa,et al. Targeted Expression of Cyclin D2 Results in Cardiomyocyte DNA Synthesis and Infarct Regression in Transgenic Mice , 2004, Circulation research.
[43] Y. Ahn,et al. Nuclear Targeting of Akt Enhances Kinase Activity and Survival of Cardiomyocytes , 2003, Circulation research.
[44] R. R. Brenner,et al. Effect of different carbon sources on Δ5 desaturation activity of HTC cells , 1991, Molecular and Cellular Biochemistry.
[45] S. Bishop,et al. Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development , 2004, Molecular and Cellular Biochemistry.
[46] T. Sjöblom,et al. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. , 2003, The American journal of pathology.
[47] L. Monassier,et al. Overexpression of the Serotonin 5-HT2B Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy , 2003, Circulation.
[48] Wenyi Wei,et al. Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. , 2002, Biochimica et biophysica acta.
[49] J. Ross,et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Cook,et al. Phenotypic Spectrum Caused by Transgenic Overexpression of Activated Akt in the Heart* , 2002, The Journal of Biological Chemistry.
[51] N. Bhattacharya,et al. Pim-1 associates with protein complexes necessary for mitosis , 2002, Chromosoma.
[52] P. Anversa,et al. bcl-2 overexpression promotes myocyte proliferation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] P. Kang,et al. Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.
[54] R. Hajjar,et al. Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo , 2001, Circulation.
[55] C. Chresta,et al. MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells. , 2001, Molecular pharmacology.
[56] R. Kitsis,et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.
[57] A. Mui,et al. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.
[58] S. Leach,et al. p21Waf1/Cip1 Inhibition of Cyclin E/Cdk2 Activity Prevents Endoreduplication after Mitotic Spindle Disruption , 1999, Molecular and Cellular Biology.
[59] B. Li,et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[60] H. Liang,et al. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1. , 1996, Archives of biochemistry and biophysics.
[61] P. Anversa,et al. ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. , 1993, The American journal of physiology.
[62] I. Weissman,et al. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[63] S. Bishop,et al. The c-myc proto-oncogene regulates cardiac development in transgenic mice , 1990, Molecular and cellular biology.